Amplimune shown to lower incidence rates of clinical mastitis and metritis and improve pregnancy rates in dairy cows
NovaVive is a private Canadian immunobiology company founded in July, 2014. The Company acquired an advanced veterinary immunotherapeutic platform based on mycobacterium cell wall fraction (MCWF) technology with regulator-approved products for cattle, horses and dogs. These products are currently sold to veterinarians in the U.S.A., Canada, Australia, New Zealand and UAE. The Company's head office is located in Napanee, Ontario, Canada.
Settle® was one of the treatments assessed in a research abstract presented at the 2025 Bain Fallon Memorial Lectures in Australia and published in SciQuest. Settle improved pregnancy outcomes in BHS-positive mares.
learn more
An abstract presented at the 2024 International Embryo Technology Society meeting summarizes a research study showing that a single treatment of Amplimune 7 days after parturition may help prevent metritis in dairy cows.
learn more
Settle® immunotherapy for equine endometritis is now available in Canada. It's also sold in the USA, Australia, New Zealand and UAE. Settle is compatible with conventional treatments and is safe with natural breeding or AI.
learn more
